1. Home
  2. ALCO vs DSGN Comparison

ALCO vs DSGN Comparison

Compare ALCO & DSGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALCO
  • DSGN
  • Stock Information
  • Founded
  • ALCO 1960
  • DSGN 2017
  • Country
  • ALCO United States
  • DSGN United States
  • Employees
  • ALCO N/A
  • DSGN N/A
  • Industry
  • ALCO
  • DSGN Biotechnology: Pharmaceutical Preparations
  • Sector
  • ALCO
  • DSGN Health Care
  • Exchange
  • ALCO Nasdaq
  • DSGN Nasdaq
  • Market Cap
  • ALCO 242.9M
  • DSGN 208.9M
  • IPO Year
  • ALCO N/A
  • DSGN 2021
  • Fundamental
  • Price
  • ALCO $32.81
  • DSGN $5.33
  • Analyst Decision
  • ALCO
  • DSGN
  • Analyst Count
  • ALCO 0
  • DSGN 0
  • Target Price
  • ALCO N/A
  • DSGN N/A
  • AVG Volume (30 Days)
  • ALCO 26.2K
  • DSGN 116.6K
  • Earning Date
  • ALCO 08-12-2025
  • DSGN 08-07-2025
  • Dividend Yield
  • ALCO 0.61%
  • DSGN N/A
  • EPS Growth
  • ALCO N/A
  • DSGN N/A
  • EPS
  • ALCO N/A
  • DSGN N/A
  • Revenue
  • ALCO $44,199,000.00
  • DSGN N/A
  • Revenue This Year
  • ALCO $15.05
  • DSGN N/A
  • Revenue Next Year
  • ALCO N/A
  • DSGN N/A
  • P/E Ratio
  • ALCO N/A
  • DSGN N/A
  • Revenue Growth
  • ALCO N/A
  • DSGN N/A
  • 52 Week Low
  • ALCO $24.23
  • DSGN $2.60
  • 52 Week High
  • ALCO $34.31
  • DSGN $7.77
  • Technical
  • Relative Strength Index (RSI)
  • ALCO 55.18
  • DSGN 68.46
  • Support Level
  • ALCO $31.70
  • DSGN $3.95
  • Resistance Level
  • ALCO $33.57
  • DSGN $5.48
  • Average True Range (ATR)
  • ALCO 0.67
  • DSGN 0.35
  • MACD
  • ALCO 0.08
  • DSGN 0.14
  • Stochastic Oscillator
  • ALCO 59.36
  • DSGN 90.23

About ALCO Alico Inc.

Alico Inc is a Florida-based agribusiness and land management company that primarily focuses on citrus production and grove conservation. The company operates through two primary business units: Alico Citrus and Land Management and Other Operations. The Alico Citrus segment engages in the cultivation of citrus trees and delivers citrus to the processed and fresh citrus markets. It mainly serves the processed market and sells primarily Hamlin oranges and the Valencia variety to the orange juice processors. The Land Management and Other Operations segment engages in land leasing for recreational, conservation, and mining activities. Alico Citrus delivers most of the revenue as the firm's primary operating business unit.

About DSGN Design Therapeutics Inc.

Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.

Share on Social Networks: